Lebanon vs Syrian Arab Republic: Treatment success rate for patients treated for MDR-TB
Lebanon
50.0%
in 2022
Syrian Arab Republic
50.0%
in 2022
Lebanon rank
139th
Syrian Arab Republic rank
139th
Treatment success rate for patients treated for MDR-TB over time
- Lebanon
- Syrian Arab Republic
How they compare
Lebanon currently reports 50.0% against 50.0% in Syrian Arab Republic, a difference of 0.0%.
The two have swapped places 9 times across 16 shared years of data; in 2007 it was Lebanon ahead.
Lebanon ranks 139th and Syrian Arab Republic ranks 139th of 163 countries.
Across the 3 decades both report, Lebanon averaged higher in 1 and Syrian Arab Republic in 2.
Head to head by decade
| Decade | Lebanon | Syrian Arab Republic | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 55.7% | 59.7% | 4.0% | Syrian Arab Republic |
| 2010s | 69.1% | 58.2% | 10.9% | Lebanon |
| 2020s | 50.0% | 62.7% | 12.7% | Syrian Arab Republic |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Lebanon or Syrian Arab Republic?
- Lebanon, at 50.0% against 50.0% in Syrian Arab Republic as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Lebanon and Syrian Arab Republic?
- 0.0%, with Lebanon ahead.
- How many years of comparable data are there for Lebanon and Syrian Arab Republic?
- 16 years are reported by both, from 2007 to 2022.
- How do Lebanon and Syrian Arab Republic rank globally for treatment success rate for patients treated for mdr-tb?
- Lebanon ranks 139th and Syrian Arab Republic ranks 139th of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.